8357 Stock Overview
Republic Healthcare Limited, an investment holding company, operates medical clinics in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Republic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.088 |
| 52 Week High | HK$0.22 |
| 52 Week Low | HK$0.071 |
| Beta | 0.33 |
| 1 Month Change | -7.37% |
| 3 Month Change | -7.37% |
| 1 Year Change | -56.00% |
| 3 Year Change | -30.71% |
| 5 Year Change | -88.57% |
| Change since IPO | -88.86% |
Recent News & Updates
Shareholder Returns
| 8357 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 2.2% |
| 1Y | -56.0% | -27.9% | -7.9% |
Return vs Industry: 8357 underperformed the Hong Kong Healthcare industry which returned -27.9% over the past year.
Return vs Market: 8357 underperformed the Hong Kong Market which returned -8.1% over the past year.
Price Volatility
| 8357 volatility | |
|---|---|
| 8357 Average Weekly Movement | 8.3% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 8357 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8357's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 37 | n/a | republichealthcare.asia |
Republic Healthcare Limited, an investment holding company, operates medical clinics in Singapore. It offers consultation, medical investigation, and treatment services; men and women’s sexual health services; and aesthetic services. The company provides its services through DTAP and S Aesthetics Clinic brands.
Republic Healthcare Limited Fundamentals Summary
| 8357 fundamental statistics | |
|---|---|
| Market cap | HK$54.91m |
| Earnings (TTM) | -HK$4.94m |
| Revenue (TTM) | HK$59.41m |
0.9x
P/S Ratio-11.1x
P/E RatioIs 8357 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8357 income statement (TTM) | |
|---|---|
| Revenue | S$10.28m |
| Cost of Revenue | S$7.58m |
| Gross Profit | S$2.70m |
| Other Expenses | S$3.55m |
| Earnings | -S$855.12k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0014 |
| Gross Margin | 26.24% |
| Net Profit Margin | -8.32% |
| Debt/Equity Ratio | 0% |
How did 8357 perform over the long term?
See historical performance and comparison